With modern treatment, people living with HIV have the same life expectancy as HIV-negative individuals. Treatment transforms the condition completely.
U=U: Undetectable = Untransmittable (The cornerstone of modern HIV management).
This principle is the global consensus of major health organizations (WHO, CDC, UNAIDS):
The most effective way to prevent transmission is to achieve and maintain an undetectable viral load. Take your meds. Love without fear.
HIV is primarily transmitted through bodily fluids (blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, and breast milk).
Progression to advanced stages is preventable and rare when treatment is initiated early.
Occurs 2–4 weeks after exposure.
Flu-like symptoms (fever, rash).
Virus multiplies rapidly (Highest transmission risk).
May have no symptoms for years.
With ART: normal health and life expectancy.
Only happens if HIV is untreated.
Defined by CD4 count <200 or opportunistic infections.
Knowing your status is the first step to management and prevention.
Simple finger prick or oral swab.
Results available in 20 minutes.
>99.6% accurate after the window period.
Detects the virus itself, as early as 10 days post-exposure.
Used for early exposure and confirmation.
Results in 24–48 hours.
100% confidential. No judgment. Walk-ins welcome for immediate testing.
| PrEP (Prevention Before Exposure) | PEP (Emergency After Exposure) | |
|---|---|---|
| Purpose | Ongoing protection for high-risk individuals. | Emergency prevention to stop the virus from taking hold. |
| When to Start | Anytime if you are at risk. | URGENT: Must start within 72 hours of potential exposure. |
| Duration | Daily (as long as risk persists). | 28 days (a full month of treatment). |
| Effectiveness | >99% for sexual transmission when taken correctly. | >80% effective, but timing is critical. |
| Cost at Irys | Subsidized programs available. | Free emergency supply available. |
Modern medication regimens are simple, highly effective, and have minimal side effects.
Dolutegravir + Tenofovir/Lamivudine (DTG/TDF/3TC).
1 tablet daily (Pill burden is low).
Minimal side effects compared to older drugs.
High resistance barrier (highly forgiving if doses are missed).
Regular blood tests confirm the treatment is working and your health is stable.
Tested every 6 months.
Goal: Undetectable (<50 copies/mL).
Tested every 12 months once viral load is stable.
Healthy range: >500 cells/mm³.
All monitoring tests are free for registered patients receiving ART at Irys.
With effective treatment, HIV-positive parents can confidently plan for healthy, HIV-negative children: